PL3817751T3 - Postacie użytkowe bezwodnego tiosiarczanu sodu - Google Patents

Postacie użytkowe bezwodnego tiosiarczanu sodu

Info

Publication number: PL3817751T3
Authority: PL; Poland
Prior art keywords: forms; anhydrous sodium; sodium thiosulfate; thiosulfate; anhydrous
Prior art date: 2018-07-03

Application number

PL19830950.2T

Other languages

English (en)

Inventor

Alexander Smith

Original Assignee

Fennec Pharmaceuticals, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-07-03

Filing date

2019-07-01

Publication date

2025-09-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=69060534&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3817751(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2019-07-01 Application filed by Fennec Pharmaceuticals, Inc. filed Critical Fennec Pharmaceuticals, Inc.

2025-09-08 Publication of PL3817751T3 publication Critical patent/PL3817751T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B17/00—Sulfur; Compounds thereof
- C01B17/64—Thiosulfates; Dithionites; Polythionates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Dermatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Physics & Mathematics (AREA)
Spectroscopy & Molecular Physics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Physics & Mathematics (AREA)
Immunology (AREA)
Pathology (AREA)
Inorganic Compounds Of Heavy Metals (AREA)

PL19830950.2T 2018-07-03 2019-07-01 Postacie użytkowe bezwodnego tiosiarczanu sodu PL3817751T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201862693502P	2018-07-03	2018-07-03
US201862693503P	2018-07-03	2018-07-03
PCT/US2019/040052 WO2020009954A1 (en)	2018-07-03	2019-07-01	Formulations of anhydrous sodium thiosulfate

Publications (1)

Publication Number	Publication Date
PL3817751T3 true PL3817751T3 (pl)	2025-09-08

Family

ID=69060534

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL19830950.2T PL3817751T3 (pl)	2018-07-03	2019-07-01	Postacie użytkowe bezwodnego tiosiarczanu sodu

Country Status (25)

Country	Link
US (17)	US20200023003A1 (pl)
EP (4)	EP4578506A3 (pl)
JP (3)	JP2021530420A (pl)
KR (2)	KR102869116B1 (pl)
CN (2)	CN112805238A (pl)
AU (3)	AU2019299217B2 (pl)
BR (2)	BR112021000021A2 (pl)
CA (2)	CA3103986A1 (pl)
DK (1)	DK3817751T3 (pl)
ES (1)	ES3036164T3 (pl)
FI (1)	FI3817751T3 (pl)
HR (1)	HRP20250792T1 (pl)
IL (2)	IL279856A (pl)
LT (1)	LT3817751T (pl)
MA (2)	MA53102A (pl)
MD (1)	MD3817751T2 (pl)
MX (4)	MX2020013733A (pl)
MY (1)	MY207630A (pl)
PL (1)	PL3817751T3 (pl)
PT (1)	PT3817751T (pl)
RS (1)	RS67043B1 (pl)
SG (2)	SG11202013199UA (pl)
SI (1)	SI3817751T1 (pl)
SM (1)	SMT202500266T1 (pl)
WO (2)	WO2020009953A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR112020016059A2 (pt)	2018-02-09	2020-12-08	Decibel Therapeutics, Inc.	Composições farmacêuticas hipertônicas contendo um agente quimioprotetor anti-platina
LT3817751T (lt)	2018-07-03	2025-08-11	Fennec Pharmaceuticals, Inc.	Bevandenio natrio tiosulfato farmaciniai preparatai
BR112021015477A2 (pt) *	2019-02-05	2021-12-28	Seagen Inc	Anticorpos anti-cd228 e conjugados anticorpo-fármaco
US10813947B1 (en)	2019-05-31	2020-10-27	Decibel Therapeutics, Inc.	Methods of otoprotection against platinum-based antineoplastic agents
US12454476B1 (en) *	2020-12-23	2025-10-28	Swamp Fox Innovations, LLC	Shelf-stable dechlorinating solutions for water and related methods for use and making thereof
EP4383335A4 (en)	2021-08-06	2025-01-22	LG Electronics Inc.	DISPLAY DEVICE
CN114848597A (zh) *	2022-07-11	2022-08-05	北京中科利华医药研究院有限公司	一种双室袋包装的硫代硫酸钠注射液和应用
CN116062708B (zh) *	2022-12-02	2024-09-17	东南大学	一种硫代硫酸钠的合成方法
WO2024145314A1 (en) *	2022-12-28	2024-07-04	Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals	Use of sodium thiosulfate for the treatment of sulfur mustard exposure

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB191512599A (en) *	1915-09-02	1916-09-04	Thomas William Staine Hutchins	Improvements in the Process for the Manufacture of Sodium Thiosulphate.
US2635980A (en) *	1950-02-11	1953-04-21	Wm S Merrell Co	Stabilized sulfa drug
GB713559A (en) *	1951-12-14	1954-08-11	Kodak Ltd	Improvements in the manufacture of the thiosulphates and seleno-sulphates of the alkali metals, calcium and ammonium
US2763531A (en) *	1952-11-29	1956-09-18	Eastman Kodak Co	Manufacture of sodium thiosulphate from sodium sulfite and sulfur in presence of cationic surface active organic bromides
DE2851037C2 (de) *	1978-11-25	1980-10-02	Dr. Franz Koehler Chemie, 6146 Alsbach	Verfahren zur Stabilisierung von für medizinische Zwecke bestimmten Natriumthiosulfat-Lösungen
US4778519A (en)	1987-02-24	1988-10-18	Batric Pesic	Recovery of precious metals from a thiourea leach
WO2001080832A2 (en) *	2000-04-26	2001-11-01	Oregon Health Sciences University	Administration of a thiol-based chemoprotectant compound
CA2479383A1 (en) *	2002-03-20	2003-10-02	Pharmacia Corporation	Storage stable eplerenone formulation
BR0306685A (pt) *	2002-05-21	2005-04-26	Daiichi Suntory Pharma Co Ltd	Composição farmacêutica contendo grelina
CN100509847C (zh)	2003-08-01	2009-07-08	安美基公司	结晶肿瘤坏死因子受体2多肽
US20070059382A1 (en)	2005-09-09	2007-03-15	Board Of Regents, Univ. And Comm. College System Of Nevada...	Medical treatment of breast cancer with boric acid materials
EP2102393A4 (en) *	2006-11-15	2011-01-05	Univ British Columbia	FOR PLATINATE COORDINATION COMPLEX-INDUCED OTOTOXICITY, PRE-DICTIVE POLYMORPHISMS
US20110077737A1 (en) *	2007-07-30	2011-03-31	Allergan, Inc.	Tunably Crosslinked Polysaccharide Compositions
US8846770B2 (en) *	2008-06-18	2014-09-30	Otonomy, Inc.	Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders
US20100016450A1 (en) *	2008-07-21	2010-01-21	Otonomy, Inc.	Controlled release delivery devices for the treatment of otic disorders
CA2734578C (en)	2008-08-18	2019-03-12	Pfizer Inc.	Antibodies to ccr2
EP4538227A3 (en) *	2009-07-08	2025-06-25	Hope Medical Enterprises, Inc. d.b.a. Hope Pharmaceuticals	Sodium thiosulfate-containing pharmaceutical compositions
IN2014MN01488A (pl) *	2011-12-23	2015-04-17	Mersana Therapeutics Inc
EP2846873B1 (fr) *	2012-05-10	2017-07-12	Institut National de la Santé et de la Recherche Medicale	Thiosulfate de sodium pour le traitement des calcifications ectopiques
JP5478680B2 (ja)	2012-08-23	2014-04-23	小林製薬株式会社	水溶性高分子増粘剤を含有する組成物の安定化剤
NL1040254C2 (en)	2013-05-17	2014-11-24	Ablynx Nv	Stable formulations of immunoglobulin single variable domains and uses thereof.
EP3046984A1 (en)	2013-09-16	2016-07-27	BASF Enzymes LLC	Controlled break enzyme formulations
EP3058082A4 (en)	2013-10-18	2017-04-26	ModernaTX, Inc.	Compositions and methods for tolerizing cellular systems
WO2015085318A2 (en)	2013-12-06	2015-06-11	Moderna Therapeutics, Inc.	Targeted adaptive vaccines
WO2015164674A1 (en)	2014-04-23	2015-10-29	Moderna Therapeutics, Inc.	Nucleic acid vaccines
CN103922292A (zh) *	2014-04-29	2014-07-16	辽宁石化职业技术学院	硫代硫酸钠的制备方法
TN2018000069A1 (en)	2015-09-01	2019-07-08	First Wave Biopharma	Methods and compositions for treating conditions associated with an abnormal inflammatory responses
MX389514B (es) *	2015-10-01	2025-03-20	Firmenich Incorporated	Compuestos útiles como moduladores de canal receptor 8 de potencial transitorio de melastatina (trpm8).
US20180230489A1 (en)	2015-10-28	2018-08-16	Voyager Therapeutics, Inc.	Regulatable expression using adeno-associated virus (aav)
CN109071450B (zh)	2015-10-30	2021-06-22	帕珀莱恩医疗公司	二苯并氮杂卓化合物及其治疗耳部疾病和病症的用途
US20170087199A1 (en)	2016-02-10	2017-03-30	Senomyx, Inc.	Compositions for delivering a cooling sensation
JP7033789B2 (ja) *	2016-06-29	2022-03-11	オトノミー，インク．	トリグリセリド耳用製剤とその使用
US20160376263A1 (en)	2016-07-26	2016-12-29	Senomyx, Inc.	Bitter taste modifiers including substituted 1-benzyl-3-(1-(isoxazol-4-ylmethyl)-1h-pyrazol-4-yl)imidazolidine-2,4-diones and compositions thereof
CN107963614A (zh) *	2016-10-20	2018-04-27	王亚玲	一种快速制备高纯度硫代硫酸钠晶体的方法
CN106379867A (zh) *	2016-10-21	2017-02-08	金川集团股份有限公司	一种生产五水硫代硫酸钠的方法
KR20250007674A (ko)	2017-03-08	2025-01-14	호프 메디칼 엔터프라이즈스, 인크, 디비에이, 호프파마수으티칼즈	티오황산 나트륨의 투석 중 용도
EP3634415A4 (en)	2017-06-08	2021-03-17	Eye Therapies, LLC	LOW DOSE COMBINATIONS OF BRIMONIDINE AND THEIR USES
US10596190B2 (en)	2017-11-29	2020-03-24	Oregon Health & Science University	Method for reducing ototoxicity in pediatric patients receiving platinum-based chemotherapy
WO2019210107A1 (en)	2018-04-25	2019-10-31	Otonomy, Inc.	Otic formulations for drug-induced ototoxicity
LT3817751T (lt) *	2018-07-03	2025-08-11	Fennec Pharmaceuticals, Inc.	Bevandenio natrio tiosulfato farmaciniai preparatai
US10813947B1 (en) *	2019-05-31	2020-10-27	Decibel Therapeutics, Inc.	Methods of otoprotection against platinum-based antineoplastic agents

2019
- 2019-07-01 LT LTEPPCT/US2019/040052T patent/LT3817751T/lt unknown
- 2019-07-01 SI SI201930947T patent/SI3817751T1/sl unknown
- 2019-07-01 SM SM20250266T patent/SMT202500266T1/it unknown
- 2019-07-01 ES ES19830950T patent/ES3036164T3/es active Active
- 2019-07-01 WO PCT/US2019/040051 patent/WO2020009953A1/en not_active Ceased
- 2019-07-01 SG SG11202013199UA patent/SG11202013199UA/en unknown
- 2019-07-01 MA MA053102A patent/MA53102A/fr unknown
- 2019-07-01 EP EP25161535.7A patent/EP4578506A3/en active Pending
- 2019-07-01 CA CA3103986A patent/CA3103986A1/en active Pending
- 2019-07-01 HR HRP20250792TT patent/HRP20250792T1/hr unknown
- 2019-07-01 BR BR112021000021-6A patent/BR112021000021A2/pt not_active Application Discontinuation
- 2019-07-01 EP EP19830950.2A patent/EP3817751B1/en active Active
- 2019-07-01 MY MYPI2020007126A patent/MY207630A/en unknown
- 2019-07-01 KR KR1020217002830A patent/KR102869116B1/ko active Active
- 2019-07-01 US US16/458,267 patent/US20200023003A1/en not_active Abandoned
- 2019-07-01 KR KR1020257032869A patent/KR20250151582A/ko active Pending
- 2019-07-01 PT PT198309502T patent/PT3817751T/pt unknown
- 2019-07-01 JP JP2020573445A patent/JP2021530420A/ja active Pending
- 2019-07-01 US US16/458,261 patent/US10792363B2/en active Active
- 2019-07-01 AU AU2019299217A patent/AU2019299217B2/en active Active
- 2019-07-01 MX MX2020013733A patent/MX2020013733A/es unknown
- 2019-07-01 WO PCT/US2019/040052 patent/WO2020009954A1/en not_active Ceased
- 2019-07-01 JP JP2020573384A patent/JP7561325B2/ja active Active
- 2019-07-01 MD MDE20210453T patent/MD3817751T2/ro unknown
- 2019-07-01 FI FIEP19830950.2T patent/FI3817751T3/fi active
- 2019-07-01 DK DK19830950.2T patent/DK3817751T3/da active
- 2019-07-01 EP EP19830258.0A patent/EP3818010A4/en not_active Withdrawn
- 2019-07-01 MX MX2020013734A patent/MX2020013734A/es unknown
- 2019-07-01 BR BR112021000022-4A patent/BR112021000022A2/pt unknown
- 2019-07-01 MA MA053101A patent/MA53101A/fr unknown
- 2019-07-01 CN CN201980044970.2A patent/CN112805238A/zh active Pending
- 2019-07-01 EP EP25182377.9A patent/EP4591939A3/en active Pending
- 2019-07-01 PL PL19830950.2T patent/PL3817751T3/pl unknown
- 2019-07-01 CN CN201980044950.5A patent/CN112805014A/zh active Pending
- 2019-07-01 CA CA3103982A patent/CA3103982A1/en active Pending
- 2019-07-01 SG SG11202013220SA patent/SG11202013220SA/en unknown
- 2019-07-01 AU AU2019299216A patent/AU2019299216A1/en not_active Abandoned
- 2019-07-01 RS RS20250651A patent/RS67043B1/sr unknown
2020
- 2020-08-28 US US17/005,997 patent/US11291728B2/en active Active
- 2020-12-15 MX MX2024003783A patent/MX2024003783A/es unknown
- 2020-12-15 MX MX2025003905A patent/MX2025003905A/es unknown
- 2020-12-30 IL IL279856A patent/IL279856A/en unknown
- 2020-12-30 IL IL279857A patent/IL279857A/en unknown
2022
- 2022-01-25 US US17/584,257 patent/US20220160875A1/en not_active Abandoned
- 2022-06-24 US US17/849,477 patent/US11510984B2/en active Active
- 2022-07-22 US US17/871,825 patent/US11617793B2/en active Active
- 2022-11-22 US US17/992,707 patent/US11992530B2/en active Active
- 2022-11-22 US US17/992,703 patent/US11998604B2/en active Active
- 2022-11-22 US US17/992,715 patent/US11964018B2/en active Active
2023
- 2023-02-20 US US18/111,844 patent/US20230201349A1/en not_active Abandoned
- 2023-02-20 US US18/111,845 patent/US20230201350A1/en not_active Abandoned
- 2023-02-20 US US18/111,849 patent/US20230201351A1/en active Pending
- 2023-09-29 US US18/375,162 patent/US20240042036A1/en active Pending
- 2023-11-06 US US18/503,027 patent/US20240350637A1/en active Pending
- 2023-11-06 US US18/503,035 patent/US20240165237A1/en active Pending
2024
- 2024-03-15 US US18/606,860 patent/US12311026B2/en active Active
- 2024-09-05 JP JP2024152867A patent/JP2024170538A/ja active Pending
2025
- 2025-06-23 AU AU2025204721A patent/AU2025204721A1/en active Pending
- 2025-07-21 US US19/275,772 patent/US20250345435A1/en active Pending

Also Published As

Publication number	Publication date
PT3817751T (pt)	2025-07-25
US11964018B2 (en)	2024-04-23
IL279857A (en)	2021-03-01
US11510984B2 (en)	2022-11-29
CA3103982A1 (en)	2020-01-09
AU2019299216A1 (en)	2021-01-07
CN112805014A (zh)	2021-05-14
US20210015923A1 (en)	2021-01-21
JP2021530420A (ja)	2021-11-11
JP7561325B2 (ja)	2024-10-04
SI3817751T1 (sl)	2025-09-30
CA3103986A1 (en)	2020-01-09
US10792363B2 (en)	2020-10-06
MX2025003905A (es)	2025-05-02
MX2020013733A (es)	2021-05-27
WO2020009954A1 (en)	2020-01-09
KR20210027410A (ko)	2021-03-10
MX2024003783A (es)	2024-04-10
AU2019299217A1 (en)	2021-01-14
US11617793B2 (en)	2023-04-04
US20220378915A1 (en)	2022-12-01
US20230094842A1 (en)	2023-03-30
LT3817751T (lt)	2025-08-11
JP2024170538A (ja)	2024-12-10
US11992530B2 (en)	2024-05-28
US20200023003A1 (en)	2020-01-23
US11998604B2 (en)	2024-06-04
EP3817751A1 (en)	2021-05-12
MX2020013734A (es)	2021-05-27
EP3818010A1 (en)	2021-05-12
EP3817751B1 (en)	2025-06-18
EP4591939A3 (en)	2025-11-05
EP3817751A4 (en)	2022-05-11
WO2020009953A1 (en)	2020-01-09
ES3036164T3 (en)	2025-09-15
MA53101A (fr)	2021-05-12
JP2021530462A (ja)	2021-11-11
KR20250151582A (ko)	2025-10-21
MY207630A (en)	2025-03-06
AU2025204721A1 (en)	2025-07-10
US20250345435A1 (en)	2025-11-13
CN112805238A (zh)	2021-05-14
US12311026B2 (en)	2025-05-27
US20200009255A1 (en)	2020-01-09
US20230094886A1 (en)	2023-03-30
US20240350637A1 (en)	2024-10-24
DK3817751T3 (da)	2025-08-18
MD3817751T2 (ro)	2025-10-31
US20240216511A1 (en)	2024-07-04
US20230201350A1 (en)	2023-06-29
US20230201351A1 (en)	2023-06-29
SG11202013220SA (en)	2021-01-28
EP4591939A2 (en)	2025-07-30
US20220160875A1 (en)	2022-05-26
US20240042036A1 (en)	2024-02-08
US20240165237A1 (en)	2024-05-23
KR20210027409A (ko)	2021-03-10
FI3817751T3 (fi)	2025-07-28
US11291728B2 (en)	2022-04-05
KR102869116B1 (ko)	2025-10-14
US20220323586A1 (en)	2022-10-13
BR112021000021A2 (pt)	2021-03-30
US20230158145A1 (en)	2023-05-25
RS67043B1 (sr)	2025-08-29
IL279856A (en)	2021-03-01
EP4578506A2 (en)	2025-07-02
BR112021000022A2 (pt)	2021-03-30
SG11202013199UA (en)	2021-01-28
SMT202500266T1 (it)	2025-09-12
MA53102A (fr)	2022-05-11
EP4578506A3 (en)	2025-08-20
EP3818010A4 (en)	2022-08-17
US20230201349A1 (en)	2023-06-29
HRP20250792T1 (hr)	2025-09-12
AU2019299217B2 (en)	2025-04-03

Publication	Publication Date	Title
PL3817751T3 (pl)	2025-09-08	Postacie użytkowe bezwodnego tiosiarczanu sodu
EP3857879A4 (en)	2022-03-16	COMBINED INTER-INTRA PREDICTION SIMPLIFICATION
IL268709A (en)	2019-10-31	Radiation source
EP3818921A4 (en)	2022-03-23	ENDOSCOPE
DK3810241T3 (da)	2022-08-15	Intuberingsindretninger
LT3645518T (lt)	2021-10-11	Omekamitivo mekarbilo sintezė
IL295119B1 (en)	2023-06-01	Intradialytic use of sodium thiosulfate
EP3347334A4 (en)	2019-05-01	DEHYDROHALOGENICATION OF FLUOROCHOLE HYDROGEN
IL282231A (en)	2021-05-31	Compounds containing deuterium
DK3741275T3 (da)	2022-02-21	Vippefastgørelsesmiddel
JP1638163S (ja)	2022-07-21	内視鏡用プロセッサ
EP3710462A4 (en)	2021-08-25	BRARTEMICIN ANALOGA
IL280047A (en)	2021-03-01	Formulation of cannabinoid compounds
IL284684A (en)	2021-08-31	Intradialytic use of sodium nitrite
SI3749673T1 (sl)	2022-07-29	Kristalinična oblika biktegravir natrija
DK3736810T3 (da)	2024-10-14	Hovedskal
EP3745939A4 (en)	2021-09-08	ENDOSCOPE
EP3844107C0 (en)	2024-04-10	PRODUCTION OF SODIUM BICARBONATE
IL280891A (en)	2021-04-29	Erbumine salt of treprostinil
EP3875023C0 (en)	2023-08-30	LARYNGOSCOPE
EP3858216A4 (en)	2021-10-27	ENDOSCOPE
EP3596357A4 (en)	2020-12-30	CHAIN PART
EP3662327A4 (en)	2021-03-03	DEVELOPERS
FIC20170021I1 (fi)	2017-05-05	deoksikoolihapon natriumsuola
EP3875463A4 (en)	2021-12-15	CYCLIC DI-AMP SODIUM SALT CRYSTAL